RSS

BNTX BioNTech SE

Last Post: 03/09/22
Followers: 0
Posts Today: 0
Views Today: 22

BNTX Stock Quote & Tools

$91.7000 ▼ -4.2500 (-4.43%) As of Jun 1, 4:00 PM EDT
Last91.7000
$ Chg-4.2500
Open97.0000
High97.4400
Beta1.3253
Year High124.000
Market Cap23.05B
P/B Ratio1.06
EPS-5.52
Avg Vol (30d)976.7K
Volume1.30M
% Chg-4.43%
Prev Close95.9500
Low91.2600
VWAP92.30898
Year Low79.520
Total Shares251.33M
Shares Out251.33M
Float208.35M
ExchangeNGS
Healthcare Biotechnology & Life Sciences

BNTX Stock Message Board Discussion

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capacitor Bank Market Growth Predictions Through 2033

Updated Category News Views 216

Capacitor Bank Market Set for Substantial Growth Recently, a comprehensive report highlighted the significant potential of the global capacitor bank market, forecasting a growth trajectory that sees its value increasing from $4.3 billion in 2023 to an impressive $6.8 billion by 2033. This translates to a compound annual growth rate (CAGR) of 4.8% during the period from...

Continue Reading
Understanding Rental Affordability Trends Across Major Markets

Updated Category News Views 291

Rental Affordability Trends in August 2024 As summer draws to a close, many renters are taking a close look at the housing market to gauge current affordability rates. A recent report highlights encouraging data, showing that rental affordability has generally improved in various major U.S. regions. This article outlines the key takeaways regarding rental affordability...

Continue Reading
Stallergenes Greer’s Palforzia® Gains European Approval for Toddlers

Updated Category News Views 134

Palforzia® Receives European Commission Approval for Toddlers Stallergenes Greer, a leader in allergen immunotherapy, has exciting news: the European Commission has officially approved the use of Palforzia® for toddlers aged 1 to 3 years with confirmed peanut allergies. This significant step enhances the treatment landscape for peanut allergies and opens new doors for...

Continue Reading
ProVen Growth and Income VCT's Latest Interim Management Insights

Updated Category News Views 174

ProVen Growth and Income VCT plc Overview ProVen Growth and Income VCT plc, known for its investment strategies and market presence, has released its Interim Management Statement for the recent quarter. This report highlights significant financial data and key developments that occurred from March to May 2025, offering shareholders insights into the company’s...

Continue Reading
Treefera Recognized as 2025 Gartner® Cool Vendor in Tech

Updated Category News Views 179

Treefera Honored as a 2025 Gartner® Cool Vendor Treefera has recently celebrated a significant milestone by being named a 2025 Gartner® Cool Vendor in Sourcing and Procurement Technology. This prestigious acknowledgment underscores Treefera's innovative contributions to the supply chain sector, particularly in providing first-mile visibility which is crucial for...

Continue Reading